[
  {
    "ts": null,
    "headline": "Why Abbott Laboratories (ABT) Story Is Shifting With Exact Sciences Deal Talk And Legal Wins",
    "summary": "Why Abbott’s Price Target Just Nudged Higher Abbott Laboratories has seen its implied fair value estimate edge to about US$144.75 from about US$144.43, a very small upward move that still matters for investors tracking the story closely. The shift sits alongside a slightly lower 7.81% discount rate and essentially unchanged long term revenue growth assumptions of about 7.64%. Together, these factors echo the Street’s mixed but generally constructive read on Abbott’s execution, medical devices...",
    "url": "https://finnhub.io/api/news?id=ebaf946eac3d8487d179b1737ff4c71725fba51e19da0c47af1f9820411e290f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768327591,
      "headline": "Why Abbott Laboratories (ABT) Story Is Shifting With Exact Sciences Deal Talk And Legal Wins",
      "id": 138086745,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Why Abbott’s Price Target Just Nudged Higher Abbott Laboratories has seen its implied fair value estimate edge to about US$144.75 from about US$144.43, a very small upward move that still matters for investors tracking the story closely. The shift sits alongside a slightly lower 7.81% discount rate and essentially unchanged long term revenue growth assumptions of about 7.64%. Together, these factors echo the Street’s mixed but generally constructive read on Abbott’s execution, medical devices...",
      "url": "https://finnhub.io/api/news?id=ebaf946eac3d8487d179b1737ff4c71725fba51e19da0c47af1f9820411e290f"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know",
    "summary": "Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=d8e2b885477324a441e68b61dc1abb6b26a4a4c09e201f7e017d6dbecd496f6e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768312802,
      "headline": "Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know",
      "id": 138086746,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=d8e2b885477324a441e68b61dc1abb6b26a4a4c09e201f7e017d6dbecd496f6e"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth",
    "summary": "Dexcom achieved FY25 revenues of around $4.66bn, corresponding to a 16% uplift over FY24.",
    "url": "https://finnhub.io/api/news?id=c064c19fd8b8a70625cead402f82645095a74157ec139a95ff41ca8a2b7cdbcc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768308700,
      "headline": "JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth",
      "id": 138083333,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Dexcom achieved FY25 revenues of around $4.66bn, corresponding to a 16% uplift over FY24.",
      "url": "https://finnhub.io/api/news?id=c064c19fd8b8a70625cead402f82645095a74157ec139a95ff41ca8a2b7cdbcc"
    }
  },
  {
    "ts": null,
    "headline": "Infant Formula Milk & Powder Market - Global Forecast 2025-2032: Abbott, Danone, Nestlé S.A., FrieslandCampina, and Bellamy's Advancing Formulation, Manufacturing Efficiency, and Global Market Reach",
    "summary": "The infant formula market presents opportunities in premiumization, digital transformation, and supply chain enhancement. Companies can leverage consumer demand for organic and plant-based options, utilize digital channels for personalized engagement, and strengthen partnerships for supply resilience and competitive positioning. Infant Formula Milk & Powder Market Infant Formula Milk & Powder Market Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The \"Infant Formula Milk & Powder Market - Global Forec",
    "url": "https://finnhub.io/api/news?id=e936bd8063a5a87b1bd4944566c893ab282c22edfdef5eb09ca17c67d30d5320",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768305660,
      "headline": "Infant Formula Milk & Powder Market - Global Forecast 2025-2032: Abbott, Danone, Nestlé S.A., FrieslandCampina, and Bellamy's Advancing Formulation, Manufacturing Efficiency, and Global Market Reach",
      "id": 138083334,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The infant formula market presents opportunities in premiumization, digital transformation, and supply chain enhancement. Companies can leverage consumer demand for organic and plant-based options, utilize digital channels for personalized engagement, and strengthen partnerships for supply resilience and competitive positioning. Infant Formula Milk & Powder Market Infant Formula Milk & Powder Market Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The \"Infant Formula Milk & Powder Market - Global Forec",
      "url": "https://finnhub.io/api/news?id=e936bd8063a5a87b1bd4944566c893ab282c22edfdef5eb09ca17c67d30d5320"
    }
  },
  {
    "ts": null,
    "headline": "Innovative Health Receives 50th FDA Clearance to Reprocess Medical Devices",
    "summary": "Innovative Health, Inc. today announced that the company has received its 50th clearance from FDA to reprocess single-use medical devices used in electrophysiology and cardiology labs. This latest clearance is to reprocess the Agilis NxT Steerable Introducer, originally manufactured by Abbott, for two additional uses in the lab. Innovative Health is the only reprocessing company that is cleared to reprocess this market-leading introducer two (2) times.",
    "url": "https://finnhub.io/api/news?id=3203b85ec737a815df4f1b950e03f92a45a32e0554d025cf51debcbb9d0d8dbc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768305600,
      "headline": "Innovative Health Receives 50th FDA Clearance to Reprocess Medical Devices",
      "id": 138083335,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Innovative Health, Inc. today announced that the company has received its 50th clearance from FDA to reprocess single-use medical devices used in electrophysiology and cardiology labs. This latest clearance is to reprocess the Agilis NxT Steerable Introducer, originally manufactured by Abbott, for two additional uses in the lab. Innovative Health is the only reprocessing company that is cleared to reprocess this market-leading introducer two (2) times.",
      "url": "https://finnhub.io/api/news?id=3203b85ec737a815df4f1b950e03f92a45a32e0554d025cf51debcbb9d0d8dbc"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 80% of the company",
    "summary": "Key Insights Institutions' substantial holdings in Abbott Laboratories implies that they have significant influence...",
    "url": "https://finnhub.io/api/news?id=57eb62cac1aa5a96eeabfea9e9e850d717a20c4cf0f2307f4a0941eb0acc2fc7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768302009,
      "headline": "Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 80% of the company",
      "id": 138083336,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Key Insights Institutions' substantial holdings in Abbott Laboratories implies that they have significant influence...",
      "url": "https://finnhub.io/api/news?id=57eb62cac1aa5a96eeabfea9e9e850d717a20c4cf0f2307f4a0941eb0acc2fc7"
    }
  }
]